Checkpoint Capital L.P. has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $150 Billion distributed in 17 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Rhythm Pharmaceuticals, Inc. with a value of $35.8B, Argenx Se with a value of $32.3B, Cytokinetics Inc with a value of $13.3B, Avadel Pharmaceuticals PLC with a value of $11.8B, and Axsome Therapeutics, Inc. with a value of $10.6B.

Examining the 13F form we can see an decrease of $15.5B in the current position value, from $165B to 150B.

Checkpoint Capital L.P. is based out at San Francisco, CA

Below you can find more details about Checkpoint Capital L.P. portfolio as well as his latest detailed transactions.

Portfolio value $150 Billion
Healthcare: $148 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 17
  • Current Value $150 Billion
  • Prior Value $165 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 4 stocks
  • Additional Purchases 7 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Checkpoint Capital L.P. Portfolio

Follow Checkpoint Capital L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Checkpoint Capital L.P., based on Form 13F filings with the SEC.

News

Stay updated on Checkpoint Capital L.P. with notifications on news.